Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Advaxis Inc (ADXS)  
$0.06 0.00 (0.00%) as of 4:30 Fri 6/3


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 66,230,000
Market Cap: 4.11(M)
Last Volume: 362,100 Avg Vol: 361,108
52 Week Range: $0.062 - $0.062
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,317,716 1,317,716
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 586
  Page 15 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bonstein Sara Chief Financial Officer   •       –      –    2015-01-30 4 A $9.85 $2,019 D/D 205 108,817     -
   Petit Robert Chief Scientific Officer   •       –      –    2014-12-31 4 D $8.01 $248 D/D (31) 112,072     -
   Petit Robert Chief Scientific Officer   •       –      –    2014-12-31 4 A $8.01 $1,858 D/D 232 112,103     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-12-31 4 D $8.01 $184 D/D (23) 118,196     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-12-31 4 A $8.01 $1,522 D/D 190 118,219     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-12-31 4 D $8.01 $64 D/D (8) 71,938     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-12-31 4 A $8.01 $825 D/D 103 71,946     -
   Mauro David J Chief Medical Officer   •       –      –    2014-12-31 4 D $8.01 $200 D/D (25) 135,788     -
   Mauro David J Chief Medical Officer   •       –      –    2014-12-31 4 A $8.01 $1,210 D/D 151 135,813     -
   O'connor Daniel Chief Executive Officer   •       •      –    2014-12-31 4 A $8.01 $6,248 D/D 780 303,919     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-12-31 4 D $8.01 $216 D/D (27) 86,017     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-12-31 4 A $8.01 $1,298 D/D 162 86,044     -
   Gross Phillip 10% Owner   –       –       •   2014-12-19 3 IO $0.00 $0 I/I 0 4,454,604     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-12-10 4 D $3.33 $73,220 D/D (21,988) 138,007     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-12-10 4 A $0.00 $0 D/D 41,799 159,995     -
   Mauro David J Chief Medical Officer   •       –      –    2014-12-10 4 D $3.33 $16,041 D/D (4,817) 140,767     -
   Mauro David J Chief Medical Officer   •       –      –    2014-12-10 4 A $0.00 $0 D/D 9,796 145,584     -
   O'connor Daniel Chief Executive Officer   •       –      –    2014-12-10 4 A $0.00 $0 D/D 51,239 355,158     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-12-10 4 A $0.00 $0 D/D 22,595 108,612     -
   Mauro David J Chief Medical Officer   •       –      –    2014-11-28 4 D $3.12 $190 D/D (61) 135,662     -
   Mauro David J Chief Medical Officer   •       –      –    2014-11-28 4 A $3.12 $1,211 D/D 388 135,723     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-11-28 4 D $3.12 $59 D/D (19) 71,843     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-11-28 4 A $3.12 $827 D/D 265 71,862     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-11-28 4 D $3.12 $218 D/D (70) 85,882     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-11-28 4 A $3.12 $1,298 D/D 416 85,952     -
  586 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 15 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us